These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 26176846)

  • 1. Role for the M1 Muscarinic Acetylcholine Receptor in Top-Down Cognitive Processing Using a Touchscreen Visual Discrimination Task in Mice.
    Gould RW; Dencker D; Grannan M; Bubser M; Zhan X; Wess J; Xiang Z; Locuson C; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2015 Oct; 6(10):1683-95. PubMed ID: 26176846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective allosteric potentiator of the M1 muscarinic acetylcholine receptor increases activity of medial prefrontal cortical neurons and restores impairments in reversal learning.
    Shirey JK; Brady AE; Jones PJ; Davis AA; Bridges TM; Kennedy JP; Jadhav SB; Menon UN; Xiang Z; Watson ML; Christian EP; Doherty JJ; Quirk MC; Snyder DH; Lah JJ; Levey AI; Nicolle MM; Lindsley CW; Conn PJ
    J Neurosci; 2009 Nov; 29(45):14271-86. PubMed ID: 19906975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M
    Gould RW; Grannan MD; Gunter BW; Ball J; Bubser M; Bridges TM; Wess J; Wood MW; Brandon NJ; Duggan ME; Niswender CM; Lindsley CW; Conn PJ; Jones CK
    Neuropharmacology; 2018 Jan; 128():492-502. PubMed ID: 28729220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents.
    Bubser M; Bridges TM; Dencker D; Gould RW; Grannan M; Noetzel MJ; Lamsal A; Niswender CM; Daniels JS; Poslusney MS; Melancon BJ; Tarr JC; Byers FW; Wess J; Duggan ME; Dunlop J; Wood MW; Brandon NJ; Wood MR; Lindsley CW; Conn PJ; Jones CK
    ACS Chem Neurosci; 2014 Oct; 5(10):920-42. PubMed ID: 25137629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Strain-dependent effects on acquisition and reversal of visual and spatial tasks in a rat touchscreen battery of cognition.
    Kumar G; Talpos J; Steckler T
    Physiol Behav; 2015 May; 144():26-36. PubMed ID: 25744936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive Allosteric Modulation of the Muscarinic M1 Receptor Improves Efficacy of Antipsychotics in Mouse Glutamatergic Deficit Models of Behavior.
    Choy KH; Shackleford DM; Malone DT; Mistry SN; Patil RT; Scammells PJ; Langmead CJ; Pantelis C; Sexton PM; Lane JR; Christopoulos A
    J Pharmacol Exp Ther; 2016 Nov; 359(2):354-365. PubMed ID: 27630144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective activation of the M1 muscarinic acetylcholine receptor achieved by allosteric potentiation.
    Ma L; Seager MA; Wittmann M; Jacobson M; Bickel D; Burno M; Jones K; Graufelds VK; Xu G; Pearson M; McCampbell A; Gaspar R; Shughrue P; Danziger A; Regan C; Flick R; Pascarella D; Garson S; Doran S; Kreatsoulas C; Veng L; Lindsley CW; Shipe W; Kuduk S; Sur C; Kinney G; Seabrook GR; Ray WJ
    Proc Natl Acad Sci U S A; 2009 Sep; 106(37):15950-5. PubMed ID: 19717450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of muscarinic receptor antagonists on cocaine discrimination in wild-type mice and in muscarinic receptor M
    Joseph L; Thomsen M
    Behav Brain Res; 2017 Jun; 329():75-83. PubMed ID: 28442355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the binding site of novel selective positive allosteric modulators at the M
    Khajehali E; Valant C; Jörg M; Tobin AB; Conn PJ; Lindsley CW; Sexton PM; Scammells PJ; Christopoulos A
    Biochem Pharmacol; 2018 Aug; 154():243-254. PubMed ID: 29777683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prefrontal Cortex-Mediated Impairments in a Genetic Model of NMDA Receptor Hypofunction Are Reversed by the Novel M
    Grannan MD; Mielnik CA; Moran SP; Gould RW; Ball J; Lu Z; Bubser M; Ramsey AJ; Abe M; Cho HP; Nance KD; Blobaum AL; Niswender CM; Conn PJ; Lindsley CW; Jones CK
    ACS Chem Neurosci; 2016 Dec; 7(12):1706-1716. PubMed ID: 27617634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using cholinergic M1 receptor positive allosteric modulators to improve memory via enhancement of brain cholinergic communication.
    Chambon C; Jatzke C; Wegener N; Gravius A; Danysz W
    Eur J Pharmacol; 2012 Dec; 697(1-3):73-80. PubMed ID: 23085025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired object-location learning and recognition memory but enhanced sustained attention in M2 muscarinic receptor-deficient mice.
    Romberg C; Bartko S; Wess J; Saksida LM; Bussey TJ
    Psychopharmacology (Berl); 2018 Dec; 235(12):3495-3508. PubMed ID: 30327842
    [TBL] [Abstract][Full Text] [Related]  

  • 13. M
    Lv X; Dickerson JW; Rook JM; Lindsley CW; Conn PJ; Xiang Z
    Neuropharmacology; 2017 May; 118():209-222. PubMed ID: 28336323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the Molecular Mechanisms of Action of Novel 4-Phenylpyridine-2-One and 6-Phenylpyrimidin-4-One Allosteric Modulators at the M
    van der Westhuizen ET; Spathis A; Khajehali E; Jörg M; Mistry SN; Capuano B; Tobin AB; Sexton PM; Scammells PJ; Valant C; Christopoulos A
    Mol Pharmacol; 2018 Jul; 94(1):770-783. PubMed ID: 29691279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potentiation of M1 Muscarinic Receptor Reverses Plasticity Deficits and Negative and Cognitive Symptoms in a Schizophrenia Mouse Model.
    Ghoshal A; Rook JM; Dickerson JW; Roop GN; Morrison RD; Jalan-Sakrikar N; Lamsal A; Noetzel MJ; Poslusney MS; Wood MR; Melancon BJ; Stauffer SR; Xiang Z; Daniels JS; Niswender CM; Jones CK; Lindsley CW; Conn PJ
    Neuropsychopharmacology; 2016 Jan; 41(2):598-610. PubMed ID: 26108886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The selective positive allosteric M1 muscarinic receptor modulator PQCA attenuates learning and memory deficits in the Tg2576 Alzheimer's disease mouse model.
    Puri V; Wang X; Vardigan JD; Kuduk SD; Uslaner JM
    Behav Brain Res; 2015; 287():96-9. PubMed ID: 25800972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M
    Hassani SA; Neumann A; Russell J; Jones CK; Womelsdorf T
    Proc Natl Acad Sci U S A; 2023 May; 120(18):e2216792120. PubMed ID: 37104474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and pharmacological evaluation of analogues of benzyl quinolone carboxylic acid (BQCA) designed to bind irreversibly to an allosteric site of the M ₁ muscarinic acetylcholine receptor.
    Davie BJ; Valant C; White JM; Sexton PM; Capuano B; Christopoulos A; Scammells PJ
    J Med Chem; 2014 Jun; 57(12):5405-18. PubMed ID: 24856614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Approach to Discovering Novel Muscarinic M
    Kurimoto E; Matsuda S; Shimizu Y; Sako Y; Mandai T; Sugimoto T; Sakamoto H; Kimura H
    J Pharmacol Exp Ther; 2018 Jan; 364(1):28-37. PubMed ID: 29025977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of stimulus salience on touchscreen serial reversal learning in a mouse model of fragile X syndrome.
    Dickson PE; Corkill B; McKimm E; Miller MM; Calton MA; Goldowitz D; Blaha CD; Mittleman G
    Behav Brain Res; 2013 Sep; 252():126-35. PubMed ID: 23747611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.